BamSEC and AlphaSense Join Forces
Learn More

CNS Pharmaceuticals Inc. – Transcripts

NASDAQ: CNSP    
Share price (7/2/26): $5.07    
Market cap (7/2/26): $7.410 million
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2026
Other Revised 06/20/26 CNS Pharmaceuticals, Inc. - Special Call 06/07/26
CY 2025
Other Revised 11/17/25 CNS Pharmaceuticals, Inc. - Shareholder/Analyst Call 11/17/25
CY 2024
Other Revised 12/12/24 CNS Pharmaceuticals, Inc. - Analyst/Investor Day 12/11/24
Other Revised 08/26/24 CNS Pharmaceuticals, Inc. Presents at Virtual Investor CEO Connect, Aug-26-2024 12:00 PM 08/26/24
Other Revised 07/30/24 CNS Pharmaceuticals, Inc. - Special Call 07/30/24
Other Revised 04/30/24 CNS Pharmaceuticals, Inc. - Shareholder/Analyst Call 04/30/24
Other Revised 04/23/24 CNS Pharmaceuticals, Inc. - Special Call 04/23/24
CY 2023
Other Revised 10/18/23 CNS Pharmaceuticals, Inc. - Pre Recorded Special Call 10/17/23
Other Revised 05/03/23 CNS Pharmaceuticals, Inc. - Special Call 05/03/23
CY 2022
Other Revised 12/06/22 CNS Pharmaceuticals, Inc. - Special Call 12/06/22
CY 2021
Other Revised 11/18/21 CNS Pharmaceuticals, Inc. Presents at Virtual Investor Roundtable Event, Nov-18-2021 09:00 AM 11/18/21
Other Revised 03/09/21 CNS Pharmaceuticals, Inc. Presents at H.C. Wainwright Virtual Global Life Sciences Conference, Mar-09-2021 07:00 AM 03/09/21
CY 2020
Other Revised 12/18/20 CNS Pharmaceuticals, Inc. - Special Call 12/18/20
Other Revised 11/12/20 CNS Pharmaceuticals, Inc. - Special Call 11/12/20
Other Revised 09/22/20 CNS Pharmaceuticals, Inc. Presents at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit, Sep-22-2020 10:00 AM 09/22/20
Other Revised 08/13/20 CNS Pharmaceuticals, Inc. - Special Call 08/13/20
Other Revised 04/22/20 CNS Pharmaceuticals, Inc. - Shareholder/Analyst Call 04/22/20